| Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers LF Kontovinis, KT Papazisis, P Touplikioti, C Andreadis, D Mouratidou, ... BMC cancer 9, 1-10, 2009 | 107 | 2009 |
| Current clinical practice guidelines for the treatment of renal cell carcinoma: a systematic review and critical evaluation A Bamias, B Escudier, CN Sternberg, F Zagouri, A Dellis, B Djavan, ... The oncologist 22 (6), 667-679, 2017 | 93 | 2017 |
| Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model A Bamias, A Karadimou, S Lampaki, G Lainakis, L Malettou, ... BMC cancer 10, 1-12, 2010 | 37 | 2010 |
| Erythropoiesis stimulating agents are associated with reduced survival in patients with multiple myeloma E Katodritou, E Verrou, C Hadjiaggelidou, V Gastari, K Laschos, ... American journal of hematology 83 (9), 697-701, 2008 | 34 | 2008 |
| Biological markers in breast cancer prognosis and treatment G Kesisis, LF Kontovinis, K Gennatas, AH Kortsaris J BUON 15 (3), 447-54, 2010 | 28 | 2010 |
| Brain natriuretic peptide precursor (NT-pro-BNP) levels predict for clinical benefit to sunitinib treatment in patients with metastatic renal cell carcinoma KT Papazisis, LF Kontovinis, CN Papandreou, G Kouvatseas, C Lafaras, ... BMC cancer 10, 1-5, 2010 | 25 | 2010 |
| Prognostic significance of low HER2 expression in patients with early hormone receptor positive breast cancer G Douganiotis, L Kontovinis, E Markopoulou, A Ainali, T Zarampoukas, ... Cancer diagnosis & prognosis 2 (3), 316, 2022 | 21 | 2022 |
| Sequential treatment with sorafenib and sunitinib in metastatic renal cell carcinoma: clinical outcomes from a retrospective clinical study L Kontovinis, K Laschos, A Karadimou, C Andreadis, A Bamias, ... Medical Oncology 29, 750-754, 2012 | 17 | 2012 |
| Targeted treatment for metastatic renal cell carcinoma and immune regulation KA Laschos, KT Papazisis, LF Kontovinis, C Kalaitzis, S Gianakopoulos, ... J BUON 15 (2), 235-240, 2010 | 11 | 2010 |
| Ribociclib and palbociclib-induced erythema multiforme: a case report E Vrana, S Mylona, M Bobos, L Kontovinis, K Papazisis Oxford Medical Case Reports 2022 (11), omac116, 2022 | 5 | 2022 |
| Real-world experience of neoadjuvant chemotherapy for early breast cancer patients: an observational non-interventional study in Thessaloniki, Greece KT Papazisis, T Liappis, L Kontovinis, A Pouptsis, S Intzes, I Natsiopoulus Greece J BUON 25 (2), 634-640, 2020 | 2 | 2020 |
| Everolimus as second-line treatment in metastatic renal cell carcinoma (mRCC) after first-line pazopanib (The RESCUE study): A retrospective analysis by the Hellenic GU Cancer … K Koutsoukos, ME Montano, L Kontovinis, K Tzannis, A Koutras, ... Journal of Clinical Oncology 33 (15_suppl), e15601-e15601, 2015 | 2 | 2015 |
| Thyroid-stimulating hormone (TSH) levels in patients with metastatic renal cell cancer treated with sunitinib T Vassileiadis, L Kontovinis, K Pazaitou, M Kontovini, D Mouratidou, ... ANNALS OF ONCOLOGY 21, 289-289, 2010 | 2 | 2010 |
| Changes in cancer tissue induced by treatment with bevacizumab in metastatic breast cancer. G Kesisis, P Touplikioti, E Yiannaki, F Paulidou, F Ziouti, M Koumpanaki, ... Journal of Clinical Oncology 28 (15_suppl), 1134-1134, 2010 | 2 | 2010 |
| Cardiac safety of neoadjuvant chemotherapy with epirubicin and cyclophosphamide followed by docetaxel/pertuzumab/trastuzumab for HER2-positive breast cancer patients G Douganiotis, S Grigoriadis, L Kontovinis, E Markopoulou, A Pouptsis, ... J BUON 26, 714-19, 2021 | 1 | 2021 |
| Economic evaluation of everolimus as second-line treatment of metastatic renal cell carcinoma in Greece A Solakidi, G Kourlaba, L Kontovinis, K Koutsoukos, E Bournakis, A Boutis, ... Value in Health 19 (7), A732, 2016 | 1 | 2016 |
| The Utility of NGS Analysis in Homologous Recombination Deficiency Tracking A Tsantikidi, E Papadopoulou, V Metaxa-Mariatou, G Kapetsis, ... Diagnostics 13 (18), 2962, 2023 | | 2023 |
| The Utility of Comprehensive NGS Analysis in Homologous Recombination Deficiency Tracking A Tsantikidi, E Papadopoulou, G Tsaousis, V Metaxa-Mariatou, ... Preprints, 2023 | | 2023 |
| The application of a multigene NGS assay in homologous recombination deficiency tracking. N Tsoulos, A Tsantikidi, E Papadopoulou, G Tsaousis, V Metaxa-Mariatou, ... Journal of Clinical Oncology 41 (16_suppl), e15169-e15169, 2023 | | 2023 |
| Economic evaluation of pazopanib as first-line treatment of metastatic renal cell carcinoma in Greece A Solakidi, G Kourlaba, L Kontovinis, E Bournakis, A Boutis, K Koutsoukos, ... Annals of Oncology 27, vi354, 2016 | | 2016 |
